| Literature DB >> 34948632 |
Claudia Lerma1, Larissa I Lima-Zapata1, Jorge A Amaya-Aguilar2, Itzel Leonardo-Cruz2, Monica Lazo-Sánchez2, Luis A Bermúdez3, Héctor Pérez-Grovas4, Abel Lerma5, Julio César Cadena-Estrada2.
Abstract
Gender and sex differences affect women with kidney failure (KF) negatively at all stages of the disease. This study assessed gender differences in self-care, hemodialysis symptoms, and quality of life in a sample of 102 adult KF patients treated with hemodialysis, from two clinical centers in Mexico. Self-care agency, quality of life, and the symptoms related to hemodialysis were evaluated through questionnaires, and sociodemographic and laboratory variables were obtained from the clinical records. Compared to male patients, female patients reported similar self-care, lower quality of life subscales (symptoms, physical functioning, pain, and overall health), and higher prevalence and intensity of hemodialysis symptoms. There were gender differences regarding the correlation between self-care and quality of life, symptoms intensity, and symptoms prevalence. In conclusion, women with KF treated with hemodialysis perceived a higher impact of hemodialysis and reported a lower quality of life than men. Despite having a similar self-care agency, the self-care correlations with quality of life and hemodialysis symptoms appeared different between men and women treated with chronic hemodialysis. Such differences may be important in future nursing interventions to improve self-care and quality of life among KF patients.Entities:
Keywords: end-stage renal disease; gender role; hemodialysis symptoms; quality of life; self-care
Mesh:
Year: 2021 PMID: 34948632 PMCID: PMC8701918 DOI: 10.3390/ijerph182413022
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Anthropometric characteristics, comorbidities, and laboratory results for 102 kidney failure (KF) patients treated with hemodialysis (HD) or hemodiafiltration. Data are shown as mean ± standard deviation, median (percentile 25–percentile 75), or absolute frequency (percentage).
| Variables | Women | Men | |
|---|---|---|---|
| Age (years) | 36.6 ± 10.7 | 39.3 ± 14.1 | 0.287 |
| Body mass index (Kg/m2) | 23.2 ± 6.5 | 23.9 ± 6.6 | 0.909 |
| Diagnosis time (months) | 5 (3–12) | 6 (3–12) | 0.886 |
| HD vintage (months) | 3 (2–5) | 3 (1–6) | 0.964 |
| Glucose (mg/dL) | 89 (76–110) | 90 (74–106) | 0.965 |
| Hemoglobin (mg/dL) | 8.75 ± 1.67 | 10.33 ± 2.10 | <0.001 |
| Creatinine (mg/dL) | 8.71 ± 1.87 | 11.87 ± 3.42 | <0.001 |
| Blood urea nitrogen (mg/dL) | 51.06 ± 19.08 | 61.83 ± 21.6 | 0.012 |
| Uric acid (mg/dL) | 5.94 ± 1.14 | 6.59 ± 1.51 | 0.023 |
| Albumin (g/dL) | 4.02 ± 0.25 | 4.12 ± 0.28 | 0.056 |
| Potassium (mEq/L) | 4.82 ± 0.62 | 4.70 ± 0.72 | 0.420 |
| Sodium (mmol/L) | 136.6 ± 3.2 | 137.8 ± 2.7 | 0.046 |
| Calcium (mg/dL) | 8.7 ± 0.8 | 8.7 ± 1.0 | 0.978 |
| Phosphorus (mg/dL) | 4.27 ± 1.69 | 5.02 ± 2.09 | 0.059 |
| KF etiology | 0.015 | ||
| Diabetes mellitus | 4 (8.5%) | 5 (9.1%) | |
| Essential hypertension | 2 (4.3%) | 13 (23.6%) | |
| Autoimmune disease | 7 (14.9%) | 2 (3.6%) | |
| Other | 34 (72.3%) | 35 (63.6%) | |
| HD mode | 0.418 | ||
| Hemodiafiltration | 21 (44.7%) | 29 (52.7%) | |
| Hemodialysis | 26 (55.3%) | 26 (47.3%) | |
| Vascular access | 0.437 | ||
| Arterio–venous fistula | 21 (46.7%) | 31 (58.5%) | |
| Tunneled catheter | 21 (46.7%) | 18 (34.0%) | |
| Non-tunneled catheter | 3 (6.7%) | 4 (7.5%) | |
| Expecting renal transplant | 21 (45.7%) | 23 (41.8%) | 0.699 |
| Arterial hypertension | 31 (70.5%) | 35 (63.6%) | 0.475 |
| Diabetes mellitus | 8 (17.0%) | 9 (16.4%) | 0.929 |
| Cardiac disease | 7(14.9%) | 9 (16.4%) | 0.839 |
| Autoimmune disease | 6 (13.0%) | 1 (1.8%) | 0.027 |
| Previous surgery | 1 (2.2%) | 1 (1.9%) | 0.909 |
| Food of drug allergies | 12 (25.5%) | 6 (10.9%) | 0.009 |
| Hepatitis B vaccine | 10 (21.3%) | 11 (20.0%) | 0.874 |
| Full vaccination scheme | 8 (17.0%) | 12 (21.8%) | 0.543 |
| Previous hospitalization | 13 (27.7%) | 9 (16.4%) | 0.167 |
| Blood transfusion | 17 (36.2%) | 16 (29.1%) | 0.446 |
| Smoking | 1 (2.1%) | 6 (10.9%) | 0.080 |
| Alcohol use | 2 (4.3%) | 7 (12.7%) | 0.133 |
Demographic characteristics of the study participants. Data are shown as mean ± standard deviation, median (percentile 25–percentile 75), or absolute frequency (percentage).
| Variables | Women | Men | |
|---|---|---|---|
| ( | ( | ||
| Monthly income (pesos) | 4000 (2000–5000) | 3200 (2000–5000) | 0.878 |
| Commute time to clinic (hours) | 1.00 (0.75–0.62) | 1.00 (0.66–0.74) | 0.742 |
| Commute expenses (pesos) | 100 (53–238) | 100 (58–150) | 0.222 |
| Education | 0.986 | ||
| Illiterate | 1 (2.1%) | 1 (1.8%) | |
| Primary/secondary school | 25 (53.2%) | 30 (54.5%) | |
| High school/College | 21 (44.7%) | 24 (43.6%) | |
| Marital status | 0.399 | ||
| Married or common-law | 27 (57.4%) | 27 (49.1%) | |
| Single, widow(er), divorced | 20 (42.6%) | 28 (50.9%) | |
| Work status | 0.341 | ||
| Unemployed | 18 (40.0%) | 14 (26.4%) | |
| Remunerated work | 22 (48.9%) | 33 (62.3%) | |
| Non-remunerated work | 5 (11.1%) | 6 (11.3%) | |
| Family structure | 0.888 | ||
| Alone | 1 (2.1%) | 2 (3.6%) | |
| Nuclear | 38 (80.9%) | 43 (78.2%) | |
| Extensive | 8 (17.0%) | 10 (18.2%) | |
| Role in the family | 0.193 | ||
| Father/mother | 22 (47.8%) | 18 (33.3%) | |
| Son/daughter | 14 (30.4%) | 23 (42.6%) | |
| Husband/wife | 9 (19.6%) | 6 (11.1%) | |
| Brother/sister | 1 (2.2%) | 4 (7.4%) | |
| Other | 0 (0.0%) | 2 (3.7%) | |
| House ownership | 0.281 | ||
| Own | 23 (48.9%) | 35 (63.6%) | |
| Borrowed | 10 (21.3%) | 10 (18.2%) | |
| Other | 14 (29.8%) | 10 (18.2%) | |
| Health insurance system | 0.660 | ||
| IMSS | 32 (69.6%) | 37 (67.3%) | |
| ISSSTE | 1 (2.2%) | 2 (3.6%) | |
| Seguro popular | 5 (10.9%) | 3 (5.5%) | |
| None/other | 8 (17.4%) | 13 (23.6%) | |
| Private health insurance | 12 (25.5%) | 14 (25.5%) | 0.993 |
IMSS: Instituto Mexicano del Seguro Social, ISSSTE: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado.
Self-care, hemodialysis (HD) symptoms, and quality of life (QoL) of the study participants. Data are shown as mean ± standard deviation or median (percentile 25–percentile 75).
| Variables | Women | Men | |
|---|---|---|---|
| Self-care | 77.1 ± 10.8 | 77.5 ± 9.9 | 0.871 |
| HD symptoms | |||
| Intensity (points) | 35.2 ± 21.8 | 22.2 ± 16.5 | 0.001 |
| Prevalence (%) | 12.7 ± 6.5 | 8.9 ± 5.1 | 0.001 |
| QoL | |||
| Total score | 68.8 ± 13.6 | 73.4 ± 11.1 | 0.064 |
| Symptoms | 83.3 (75.0–89.5) | 89.5 (79.1–93.7) | 0.002 |
| Disease effect | 68.7 (62.5–81.2) | 78.1 (68.7–90.6) | 0.074 |
| Renal disease load | 50 (25–69) | 50 (31–75) | 0.688 |
| Work status | 50 (50–100) | 50 (0–100) | 0.721 |
| Cognitive function | 86.6 (66.6–100.0) | 86.6 (73.3–100.0) | 0.499 |
| Social interaction quality | 86.6 (66.6–100.0) | 86.6 (66.6–93.3) | 0.560 |
| Sexual function | 93.7 (56.2–100.0) | 100.0 (65.6–100.0) | 0.640 |
| Sleep | 56.6 (50–63.3) | 60.0 (53.3–63.3) | 0.114 |
| Social support | 83.3 (66.6–100.0) | 83.3 (66.6–100.0) | 0.543 |
| Positive interaction with health staff | 75.0 (62.5–100.0) | 87.5 (75.0–100.0) | 0.105 |
| Patient’s satisfaction | 83.3 (50.0–100.0) | 83.3 (66.6–100.0) | 0.608 |
| Physical functioning | 70 (40–80) | 75 (60–90) | 0.033 |
| Physical role | 50 (25–100) | 75 (25–100) | 0.446 |
| Pain | 68 (55–90) | 88 (68–100) | 0.039 |
| Overall health | 50 (45–65) | 65 (50–75) | 0.041 |
| Emotional status | 80 (64–92) | 84 (76–96) | 0.063 |
| Emotional role | 100 (67–100) | 100 (100–100) | 0.307 |
| Social function | 75 (63–100) | 88 (63–100) | 0.497 |
| Fatigue/energy | 60 (40–80) | 70 (55–80) | 0.044 |
Spearman correlation coefficients for quality of life (QoL), self-care, and HD symptoms in 102 KF patients. Significant correlations (p < 0.05) are indicated with an asterisk (*).
| Self-Care | HD Symptoms | HD Symptoms | ||||
|---|---|---|---|---|---|---|
| Variables | Women | Men | Women | Men | Women | Men |
| Total score | 0.415 * | 0.293 * | −0.539 * | −0.512 * | −0.580 * | −0.513 * |
| Symptoms | 0.167 | 0.040 | −0.660 * | −0.631 * | −0.757 * | −0.610 * |
| Disease effect | 0.380 * | 0.137 | −0.391 * | −0.403 * | −0.350 * | −0.409 * |
| Renal disease load | 0.463 * | 0.228 | −0.320 * | −0.294 * | −0.317 * | −0.331 * |
| Work status | 0.030 | 0.037 | −0.175 | −0.171 | −0.261 | −0.120 |
| Cognitive function | 0.328 * | 0.002 | −0.396 * | −0.573 * | −0.485 * | −0.556 * |
| Social interaction quality | 0.151 | 0.216 | −0.416 * | −0.455 * | −0.497 * | −0.453 * |
| Sexual function | 0.297 | 0.091 | −0.112 | −0.165 | −0.240 | −0.237 |
| Sleep | 0.155 | 0.375 * | −0.334 * | −0.363 * | −0.446 * | −0.390 * |
| Social support | 0.295 * | 0.158 | −0.261 | −0.173 | −0.246 | −0.114 |
| Positive interaction with health staff | 0.284 | 0.132 | 0.133 | −0.082 | 0.159 | −0.011 |
| Patient’s satisfaction | 0.340 * | 0.021 | 0.062 | 0.003 | 0.113 | −0.001 |
| Physical functioning | 0.297 * | 0.270 * | −0.249 | −0.233 | −0.196 | −0.204 |
| Physical role | 0.163 | 0.158 | −0.349 * | −0.104 | −0.347 * | −0.119 |
| Pain | 0.081 | 0.095 | −0.546 * | −0.479 * | −0.564 * | −0.485 * |
| Overall health | 0.273 | 0.069 | −0.295 * | −0.132 | −0.333 * | −0.157 |
| Emotional status | 0.297 * | 0.189 | −0.603 * | −0.468 * | −0.669 * | −0.469 * |
| Emotional role | 0.048 | 0.158 | −0.351 * | −0.268 * | −0.438 * | −0.298 * |
| Social function | 0.210 | 0.181 | −0.493 * | −0.377 * | −0.488 * | −0.392 * |
| Fatigue/energy | 0.300 * | 0.272 * | −0.552 * | −0.450 * | −0.575 * | −0.419 * |
QoL: quality of life.
Spearman correlation coefficients between self-care and ordinal variables. Significant correlation (p < 0.05) is indicated with an asterisk (*).
| Variables | All Patients | Women | Men |
|---|---|---|---|
| Age (years) | 0.058 | 0.009 | 0.093 |
| Body mass index (Kg/m2) | −0.190 | −0.113 | −0.259 |
| Diagnosis time (months) | 0.051 | 0.104 | −0.023 |
| HD vintage (months) | −0.078 | −0.086 | −0.105 |
| Hemoglobin (mg/dL) | −0.049 | 0.014 | −0.061 |
| Glucose (mg/dL) | −0.185 | −0.257 | −0.136 |
| Creatinine (mg/dL) | −0.056 | −0.227 | 0.032 |
| Blood urea nitrogen (mg/dL) | −0.001 | −0.115 | 0.123 |
| Uric acid (mg/dL) | −0.121 | −0.179 | −0.062 |
| Albumin (g/dL) | 0.170 | 0.146 | 0.194 |
| Potassium (mEq/L) | 0.028 | −0.139 | 0.163 |
| Sodium (mmol/L) | 0.043 | 0.119 | 0.024 |
| Calcium (mg/dL) | −0.093 | −0.072 | −0.122 |
| Phosphorous (mg/dL) | −0.081 | −0.070 | −0.108 |
| Monthly income | −0.009 | 0.017 | −0.044 |
| Commute time to clinic (hours) | 0.213 * | 0.206 | 0.220 |
| Commute expenses (pesos) | 0.094 | 0.167 | 0.027 |
| Prevalence HD symptoms | −0.050 | −0.175 | 0.019 |
| Intensity HD symptoms | −0.018 | −0.081 | 0.003 |
Self-care score compared by gender for the studied nominal variables.
| Variable | Women | Men |
|---|---|---|
| ( | ( | |
| Diabetes Mellitus | ||
| Yes | 69.9 ± 17.5 | 77.7 ± 8.1 |
| No | 78.7 ± 8.6 a | 77.5 ± 10.4 |
| Arterial hypertension | ||
| Yes | 75.4 ± 11.8 | 77.4 ± 10.2 |
| No | 80.6 ± 7.9 | 77.6 ± 9.7 |
| Cardiac disease | ||
| Yes | 72 ± 11.7 | 75.9 ± 10.4 |
| No | 78 ± 10.62 | 77.8 ± 9.9 |
| Allergy | ||
| Yes | 78.1 ± 13.8 | 74.3 ± 3.5 |
| No | 76.8 ± 9.8 | 77.8 ± 10.4 |
| Previous hospitalization | ||
| Yes | 76.1 ± 12.0 | 80.7 ± 9.6 |
| No | 77.5 ± 10.5 | 76.8 ± 10.0 |
| Previous transfusion | ||
| Yes | 76.4 ± 11.8 | 80.3 ± 7.8 |
| No | 77.5 ± 10.4 | 76.3 ± 10.5 |
| Alcohol drinking | ||
| Yes | 75 ± 8.2 | 80 ± 7.6 |
| No | 77.2 ± 11 | 77.1 ± 10.2 |
| Education | ||
| Illiterate, primary or secondary | 75.2 ± 13 | 77.1 ± 9.7 |
| High school or college | 79.5 ± 6.9 | 77.9 ± 10.4 |
| Marital status | ||
| Married/common-law partner | 77 ± 10.4 | 78 ± 10.6 |
| Single/widow(er)/divorced | 77.3 ± 11.6 | 77 ± 9.4 |
| Work status | ||
| Remunerated work | 73.1 ± 10.5 | 78.4 ± 10.1 |
| Unemployed/Non-remunerated | 75.5 ± 11.0 | 76 ± 10.1 |
| House ownership | ||
| Own | 76.8 ± 14.1 | 76.1 ± 11.1 |
| Borrowed | 79.4 ± 6.8 | 79.4 ± 81.6 |
| Other | 76.1 ± 6.5 | 76.1 ± 8 |
| Health insurance system | ||
| Government agency | 77.4 ± 10.06 | 76.7 ± 10.1 |
| None/other | 74.1 ± 14.3 | 79.8 ± 9.2 |
| Private health insurance | ||
| Yes | 77.2 ± 9.8 | 79.1 ± 10.1 |
| No | 77.1 ± 11.3 | 76.93 ± 9.9 |
| Hemodialysis mode | ||
| Hemodiafiltration | 80.6 ± 6.9 | 78.5 ± 7.8 |
| Hemodialysis | 74.3 ± 12.6 b | 76.3 ± 11.9 |
| Vascular access | ||
| Arterio-venous fistula | 79.4 ± 9.6 | 78.1 ± 7.5 |
| Tunneled catheter | 74.7 ± 12.1 | 73.6 ± 12.4 |
| Non-tunneled catheter | 81.1 ± 13.0 | 86 ± 10.5 |
a p < 0.05 vs. women with diabetes mellitus. b p < 0.05 vs. women treated with hemodiafiltration.